RIPK1-IN-15
RIPK1-IN-15 (Compound 2.5) is a potent inhibitor of RIPK1. RIPK1-IN-15 has the potential for the research neurodegenerative, autoimmune, and inflammatory diseases[1].
Product Specifications
CAS Number
2755704-34-6
UNSPSC
12352005
Target
RIP kinase
Type
Reference compound
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/ripk1-in-15.html
Solubility
10 mM in DMSO
Smiles
O=C(N1N=CC[C@H]1C2=CC=CC=C2)N3CC(OC4=CC=CC=C4)C3
Molecular Formula
C19H19N3O2
Molecular Weight
321.37
References & Citations
[1]Sabnis RW. Novel RIPK1 Inhibitors for Treating Neurodegenerative, Autoimmune, and Inflammatory Diseases. ACS Med Chem Lett. 2022 Mar 2;13 (4) :524-525.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
RIPK1
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog